Clinical trial

Tocilizumab Real-Life Human Factors (RLHFs) Validation Study

NCT02682823

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-21

PhasePHASE4

Study timeline

Study start (actual)2016-03-21Date precision: day

Registry last updated2019-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

AI-1000 G2DEVICE

TocilizumabDRUG · verified · RxNorm: tocilizumab

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

DallasTexas, United States1 LexingtonKentucky, United States1 TulsaOklahoma, United States1 MesaArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02682823 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.